Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Editas Medicine, Inc. | edit-20161231ex3128ff2a2.htm |
| 10-K - 10-K - Editas Medicine, Inc. | edit-20161231x10k.htm |
| EX-32.1 - EX-32.1 - Editas Medicine, Inc. | edit-20161231ex321ea3deb.htm |
| EX-31.1 - EX-31.1 - Editas Medicine, Inc. | edit-20161231ex3116a97ce.htm |
| EX-10.16 - EX-10.16 - Editas Medicine, Inc. | edit-20161231ex101675c19.htm |
| EX-10.12 - EX-10.12 - Editas Medicine, Inc. | edit-20161231ex1012f151f.htm |
| EX-10.11 - EX-10.11 - Editas Medicine, Inc. | edit-20161231ex101166626.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2013 Stock Incentive Plan, the 2015 Stock Incentive Plan and the 2015 Employee Stock Purchase Plan of Editas Medicine, Inc. of our report dated March 3, 2017, with respect to the consolidated financial statements of Editas Medicine, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2016.
|
|
/s/ Ernst & Young LLP |
Boston, Massachusetts
March 3, 2017